Related Experiment Video
Updated: Jul 19, 2026
10:25
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Haemostasis
J Arnout1, M F Hoylaerts, H R Lijnen
1Centre for Molecular and Vascular Biology, KU Leuven, Campus Gasthuisberg, O & N, 1, Box 911, Herestraat 49, 3000 Leuven, Belgium.
Handbook of Experimental Pharmacology
|September 27, 2006
Summary
Platelets and fibrin form clots to seal vascular injuries. A balance of coagulation and fibrinolysis maintains blood vessel function and prevents thrombosis.
Area of Science:
- Physiology
- Biochemistry
- Hematology
Background:
- Vascular injury triggers platelet and fibrin clot formation for hemostasis.
- Hemostasis involves primary (platelet) and secondary (coagulation) processes.
- Fibrinolysis dissolves clots when no longer needed.
Purpose of the Study:
- To describe the physiological processes of hemostasis and fibrinolysis.
- To highlight the roles of key molecules like von Willebrand factor and thrombin.
- To explain the regulatory mechanisms preventing excessive clotting.
Main Methods:
- Review of physiological pathways involved in blood clotting and clot dissolution.
- Description of molecular interactions in platelet adhesion, activation, and aggregation.
- Explanation of the coagulation cascade and its regulation.
- Overview of the fibrinolytic system activation and inhibition.
Main Results:
- Von Willebrand factor initiates platelet recruitment to injured vessels.
- Coagulation factors generate thrombin, converting fibrinogen to fibrin.
- Antithrombin and the protein C pathway regulate thrombin generation.
- Plasminogen activators convert plasminogen to plasmin, which degrades fibrin.
- Plasminogen activator inhibitors and alpha2-antiplasmin inhibit fibrinolysis.
Conclusions:
- Hemostasis relies on a coordinated interplay between platelet function and the coagulation cascade.
- The fibrinolytic system counterbalances coagulation to prevent thrombosis.
- These integrated systems maintain vascular integrity and a non-thrombotic state.
Related Concept Videos
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...